Future studies with higher symptom scoring resolution, such as mild/moderate, severe, and death, could elucidate the potential associations of DVG abundance and/or frequency with viral load, IFN responses, and COVID-19 disease severity. This evidence concerns the gene IFNA1 and COVID-19.